Theraclion SA
PAR:ALTHE

Watchlist Manager
Theraclion SA Logo
Theraclion SA
PAR:ALTHE
Watchlist
Price: 0.77 EUR -3.27% Market Closed
Market Cap: €36.2m

Net Margin

-276%
Current
Improving
by 147%
vs 3-y average of -423%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-276%
=
Net Income
€-5.3m
/
Revenue
€1.9m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-276%
=
Net Income
€-5.3m
/
Revenue
€1.9m

Peer Comparison

Country Company Market Cap Net
Margin
FR
Theraclion SA
PAR:ALTHE
35.7m EUR
Loading...
US
Abbott Laboratories
NYSE:ABT
184.5B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.3B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
136.2B USD
Loading...
US
Stryker Corp
NYSE:SYK
135.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.4B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.3B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
46.8B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.4B USD
Loading...

Market Distribution

Lower than 92% of companies in France
Percentile
8th
Based on 2 398 companies
8th percentile
-276%
Low
-147 400% — -2.2%
Typical Range
-2.2% — 7.1%
High
7.1% — 14 243.8%
Distribution Statistics
France
Min -147 400%
30th Percentile -2.2%
Median 2.6%
70th Percentile 7.1%
Max 14 243.8%

Theraclion SA
Glance View

Market Cap
36.2m EUR
Industry
Health Care

Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.

ALTHE Intrinsic Value
0.06 EUR
Overvaluation 92%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-276%
=
Net Income
€-5.3m
/
Revenue
€1.9m
What is Theraclion SA's current Net Margin?

The current Net Margin for Theraclion SA is -276%, which is above its 3-year median of -423%.

How has Net Margin changed over time?

Over the last 3 years, Theraclion SA’s Net Margin has increased from -497.5% to -276%. During this period, it reached a low of -703.9% on Jun 30, 2024 and a high of -201.7% on Dec 31, 2023.

Back to Top